Clinical Trial Update: Phase I/II Study Evaluating PSMA Targeted Radionuclide Therapy in Adult Patients With Metastatic Clear Cell Renal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II study evaluating PSMA-targeted radionuclide therapy in adults with metastatic clear cell renal cell carcinoma has completed its Phase 1 and Phase 2 p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma

Snippet

Sponsor: Centre Leon Berard | Conditions: Metastatic Clear Cell Renal Cell Carcinoma | Phase 1, Phase 2 | Status: COMPLETED